(FM) Medicina Nuclear
Departamento académico
University of Genoa
Génova, ItaliaPublicaciones en colaboración con investigadores/as de University of Genoa (9)
2022
-
Correction to: EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3 (European Journal of Nuclear Medicine and Molecular Imaging, (2022), 49, 2, (632-651), 10.1007/s00259-021-05603-w)
European Journal of Nuclear Medicine and Molecular Imaging
-
EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 49, Núm. 2, pp. 632-651
2020
-
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias
The Lancet Neurology, Vol. 19, Núm. 11, pp. 951-962
2019
-
Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC)
NeuroImage: Clinical, Vol. 23
2018
-
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus
European Journal of Neurology, Vol. 25, Núm. 10, pp. 1201-1217
-
Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, Núm. 9, pp. 1557-1566
-
Clinical utility of FDG-PET for the clinical diagnosis in MCI
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, Núm. 9, pp. 1497-1508
-
Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, Núm. 9, pp. 1546-1556
2013
-
Appropriate use criteria for amyloid PET imaging cannot replace guidelines: On behalf of the European Association of Nuclear Medicine
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 40, Núm. 7, pp. 1122-1125